Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Bergentoft Pharma Consulting AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 1 More Arrow 179 More Arrow 185
Financial expenses 1 Equal arrow 1 Less Arrow 0
Earnings before taxes -7 More Arrow 156 Less Arrow 114
EBITDA -14 More Arrow 155 Less Arrow 114
Total assets 276 More Arrow 359 Less Arrow 264
Current assets 180 More Arrow 273 Less Arrow 174
Current liabilities 9 More Arrow 56 More Arrow 69
Equity capital 246 More Arrow 280 Less Arrow 181
- share capital 4 More Arrow 5 Less Arrow 4
Employees (average) 1 More Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 89.1% Less Arrow 78.0% Less Arrow 68.6%
Turnover per employee 1 More Arrow 90 More Arrow 185
Profit as a percentage of turnover -700% More Arrow 87.2% Less Arrow 61.6%
Return on assets (ROA) -2.2% More Arrow 43.7% Less Arrow 43.2%
Current ratio 2000% Less Arrow 487.5% Less Arrow 252.2%
Return on equity (ROE) -2.8% More Arrow 55.7% More Arrow 63.0%
Change turnover -172 More Arrow -6 More Arrow 79
Change turnover % -100% More Arrow -3% More Arrow 75%
Chg. No. of employees -1 More Arrow 1 Less Arrow 0
Chg. No. of employees % -50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.